Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK8141 in Hypertensive Patients
NCT00543413Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of MK-8141 in hypertension (HTN), sponsored by Merck & Co. Started Oct 2007; status: completed.
02
Drugs
MK-8141
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00543413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543413.